Form 4: Definitive Healthcare Director Jill Larsen Granted Over 55,000 Restricted Stock Units

Definitive Healthcare Corp. director Jill Larsen was granted 55,911 restricted stock units (RSUs) on June 5, 2025, increasing her total beneficial ownership to 114,751 shares.

Summary

• Jill Larsen, a Director of Definitive Healthcare Corp. (DH), was granted 55,911 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs).
• The transaction date for this grant was June 5, 2025.
• These RSUs were acquired at a price of $0, which is typical for equity grants.
• Following this transaction, Ms. Larsen's total beneficial ownership in Definitive Healthcare Corp. stands at 114,751 shares of Class A Common Stock.
• The RSUs are scheduled to vest on the earlier of June 5, 2026, or the date of the Issuer's next annual meeting of stockholders, contingent upon Ms. Larsen's continued service.

Sentiment

Score: 6

Explanation: The RSU grant is a standard compensation event that aligns director interests with shareholders, indicating stability in governance and compensation practices. It's a neutral to slightly positive event.

Positives

• The grant of Restricted Stock Units (RSUs) to Director Jill Larsen aligns her interests with those of shareholders, as the value of her compensation is tied to the company's stock performance.
• Equity compensation is a common practice to incentivize long-term commitment and performance from key personnel.

Negatives

• No direct negative implications are apparent from this standard equity grant.

Risks

• The RSUs are subject to forfeiture if the reporting person's service to the company ceases before the vesting date.

Future Outlook

The RSU grant with a future vesting date indicates an expectation of continued service from Director Jill Larsen through at least June 5, 2026, or the next annual meeting.

Industry Context

The granting of Restricted Stock Units (RSUs) to directors is a common form of equity compensation across various industries, including the healthcare technology sector where Definitive Healthcare operates. This practice is used to attract, retain, and incentivize experienced board members by aligning their financial interests with the long-term performance of the company.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as a component of director compensation is a widely accepted practice, comparable to compensation structures seen in other publicly traded healthcare technology companies like Veeva Systems (VEEV) or IQVIA (IQV), which also utilize equity grants to incentivize their leadership.
• The vesting schedule, tied to continued service and a specific future date or the next annual meeting, is standard for such grants, ensuring alignment with long-term company performance and governance.

Corporate Governance

Related Party Transactions

• The grant of 55,911 Restricted Stock Units to Jill Larsen, a director of Definitive Healthcare Corp., constitutes a related party transaction as it involves compensation provided by the company to an insider.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's financial incentives with shareholder interests, potentially leading to better long-term performance.

Next Steps

• Vesting of the 55,911 Restricted Stock Units on the earlier of June 5, 2026, or the date of the Issuer's next annual meeting of stockholders, subject to continued service.

Key Dates

Keywords

Definitive Healthcare, DH, Form 4, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Grant, Beneficial Ownership